Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation.
Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation.
复制标题
DOI:
10.1371/journal.pone.0009646
复制
发表时间:
2010-03-19
期刊:
影响因子:
3.7
通讯作者:
Mahajan NP
中科院分区:
文献类型:
--
作者:
Mahajan K;Coppola D;Challa S;Fang B;Chen YA;Zhu W;Lopez AS;Koomen J;Engelman RW;Rivera C;Muraoka-Cook RS;Cheng JQ;Schönbrunn E;Sebti SM;Earp HS;Mahajan NP
The AKT/PKB kinase is a key signaling component of one of the most frequently activated pathways in cancer and is a major target of cancer drug development. Most studies have focused on its activation by Receptor Tyrosine Kinase (RTK) mediated Phosphatidylinositol-3-OH kinase (PI3K) activation or loss of Phosphatase and Tensin homolog (PTEN). We have uncovered that growth factors binding to RTKs lead to activation of a non-receptor tyrosine kinase, Ack1 (also known as ACK or TNK2), which directly phosphorylates AKT at an evolutionarily conserved tyrosine 176 in the kinase domain. Tyr176-phosphorylated AKT localizes to the plasma membrane and promotes Thr308/Ser473-phosphorylation leading to AKT activation. Mice expressing activated Ack1 specifically in the prostate exhibit AKT Tyr176-phosphorylation and develop murine prostatic intraepithelial neoplasia (mPINs). Further, expression levels of Tyr176-phosphorylated-AKT and Tyr284-phosphorylated-Ack1 were positively correlated with the severity of disease progression, and inversely correlated with the survival of breast cancer patients. Thus, RTK/Ack1/AKT pathway provides a novel target for drug discovery.
登录
查看更多内容
DOI:
10.1073/pnas.0700420104
发表时间:
2007-05-15
影响因子:
11.1
作者:
Mahajan, Nupam P.;Liu, Yuanbo;Whang, Young E.
通讯作者:
Whang, Young E.
影响因子:
4
作者:
Huang, Haojie;Tindall, Donald J.
通讯作者:
Tindall, Donald J.
影响因子:
64.8
作者:
MANSER, E;LEUNG, T;LIM, L
通讯作者:
LIM, L
影响因子:
4.8
作者:
Kiyono, M;Kato, J;Satoh, T
通讯作者:
Satoh, T
影响因子:
64.8
作者:
BURGERING, BMT;COFFER, PJ
通讯作者:
COFFER, PJ